Proof-of-concept reported for HIV microbicide

Tuesday 20 July 2010

An antiretroviral-based microbicide that includes the drug, tenofovir, has been shown in a Phase 2b trial to moderately protect women against sexually-transmitted HIV. The trial results were released at an international AIDS conference in Vienna.

.

  

 

 

 

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Austria